Innova Biosciences

Cambridge, United Kingdom Founded: 2002 • Age: 24 yrs Acquired By Abcam
Antibody labeling and bioconjugation kits are developed and marketed.
Request Access

About Innova Biosciences

Innova Biosciences is a company based in Cambridge (United Kingdom) founded in 2002 was acquired by Abcam in November 2019.. Innova Biosciences has raised $196.74 thousand across 3 funding rounds from investors including Abcam and SYGNIS. The company has 1,587 employees as of January 31, 2021. Innova Biosciences operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.

  • Headquarter Cambridge, United Kingdom
  • Employees 1587 as on 31 Jan, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Abcam Limited
  • Date of Incorporation 12 Feb, 1998
  • Jurisdiction CAMBRIDGE, UNITED KINGDOM
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
    $333.72 M (USD)
    0
    as on Dec 31, 2020
  • Net Profit
    $16.04 M (USD)
    0
    as on Dec 31, 2020
  • EBITDA
  • Total Equity Funding
    $196.74 K (USD)

    in 3 rounds

  • Latest Funding Round
    $337.28 K (USD), Grant

    May 16, 2012

  • Investors
    Abcam

    & 1 more

  • Employee Count
    1587

    as on Jan 31, 2021

  • Acquired by
    Abcam

    & 1 more

    (Nov 11, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Innova Biosciences

Innova Biosciences has successfully raised a total of $196.74K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $337.28 thousand completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $337,281
  • First Round

    (25 Jun 2007)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2012 Amount Grant - Innova Biosciences Valuation

investors

Feb, 2009 Amount Grant - Innova Biosciences Valuation

investors

Jun, 2007 Amount Seed - Innova Biosciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Innova Biosciences

Innova Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Abcam and SYGNIS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Biological reagents and antibodies are developed for life science research.
Founded Year Domain Location
SYGNIS provides molecular biology reagents for research and laboratory applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Innova Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Innova Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Innova Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Innova Biosciences

Innova Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Monoclonal antibody technology and products are developed by Epitomics.
domain founded_year HQ Location
Developer of antibodies for the treatment of multiple diseases
domain founded_year HQ Location
Antibodies and immunoassay kits are developed for research applications.
domain founded_year HQ Location
Antibody and vaccine culture media products are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Innova Biosciences

Frequently Asked Questions about Innova Biosciences

When was Innova Biosciences founded?

Innova Biosciences was founded in 2002 and raised its 1st funding round 5 years after it was founded.

Where is Innova Biosciences located?

Innova Biosciences is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.

Is Innova Biosciences a funded company?

Innova Biosciences is a funded company, having raised a total of $196.74K across 3 funding rounds to date. The company's 1st funding round was a Seed of $196.74K, raised on Jun 25, 2007.

How many employees does Innova Biosciences have?

As of Jan 31, 2021, the latest employee count at Innova Biosciences is 1,587.

What is the annual revenue of Innova Biosciences?

Annual revenue of Innova Biosciences is $333.72M as on Dec 31, 2020.

What does Innova Biosciences do?

Innova Biosciences is engaged in the development, manufacturing and marketing of antibody labeling and bioconjugation kits. The company offers a variety of antibody labeling kits (enzyme , fluorescent protein, biotinstreptavidin, tandem, and fluorescent dye tags). In addition, it offers antibody purification kits, gold conjugation kits, immunogen kits, maleimide activated labels, substrates and stabilizers, phosphate detection assays, and affinity resins. On September 19, 2016, the company launched a new product AbPure Magnetic Purification system- the system is based on Protein A Magnetic Beads, with high affinity for IgG molecules thus allowing to purify small quantities of antibody from complex mixtures.

Who are the top competitors of Innova Biosciences?

Innova Biosciences's top competitors include Sino Biological, GenScript and Y-Biologics.

Who are Innova Biosciences's investors?

Innova Biosciences has 2 investors. Key investors include Abcam, and SYGNIS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available